Page last updated: 2024-11-04

sulfamethoxazole and Myocarditis

sulfamethoxazole has been researched along with Myocarditis in 1 studies

Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.

Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bousquet, A1
Bigaillon, C1
Dumitrescu, N1
Larréché, S1
Godreuil, C1
Mestiri, R1
Le Caruyer, N1
Mérens, A1
Andriamanantena, D1

Other Studies

1 other study available for sulfamethoxazole and Myocarditis

ArticleYear
Acute myocarditis in an immunocompetent young man: Don't forget Toxoplasma gondii.
    International journal of cardiology, 2016, Jul-01, Volume: 214

    Topics: Catheter-Related Infections; Diagnosis, Differential; Humans; Magnetic Resonance Imaging, Cine; Male

2016